Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VYNT-0126 (Donepezil) in Adult Rett Syndrome
NCT05625568Phase 2Unknown
- Sponsor
- Vyant Bio, Inc.
- Start
- Mar 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of donepezil in Rett syndrome (RTT), sponsored by Vyant Bio, Inc.. Status: unknown.
02
Drugs
donepezil
03
Conditions
Rett syndrome (RTT)
Beyond the preview
Go deeper on NCT05625568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05625568.